Pay in 4 interest-free payments of $6.55 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Mortality gains from these drugs could change how we view metabolic risks in underwriting and unlock new opportunities to design and offer products centered around different metabolic risk profiles
As newer incretin therapies continue to emerge, clinicians will likely gain additional tools for addressing diminished response to GLP-1 medications
This article describes the discovery and preclinical characterization of the first long-acting GLP1R GIPR co-agonist
The platform prescribes both brand-name and compounded GLP-1s and also includes a community portal and coaching support
Dehydration has a direct and immediate impact on energy levels
Important single nucleotide polymorphisms (SNPs) in the FTO gene, such as rs9939609 and rs1421085, have been shown to be associated with a higher risk for high BMI, increased fatty mass, and altered dietary habits, including a tendency to consume energy-dense and high-fat foods
